Pain control study for oral cancer surgery
Part of Cancer, Mouth & dental clinical trials.
This study tests two different pain medicines (dezocine or nalbuphine) combined with sufentanil to see which helps better control pain after oral cancer surgery with free flap reconstruction. It also looks at side effects and how well the transplanted tissue survives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with oral cancer (a malignant tumor in your mouth).
- You are scheduled for oral cancer surgery that uses a free flap (a piece of tissue from another part of your body) to rebuild the surgery area.
- You have not used pain medications in the last two weeks.
- You do not have diabetes, hardened arteries, or blood vessel disease.
- You are not currently using hormones, chemotherapy, or immune-suppressing drugs.
- You are not allergic to the study drugs (dezocine, nalbuphine, or sufentanil).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines, sufentanil and methadone, for pain control after head and neck surgery that uses a flap to rebuild tissue. The goal is to find which option works better and has fewer side effects.
This trial tests whether a new under-the-tongue pain medication (sublingual sufentanil) helps people recover better after surgery compared to standard oral pain relief. You'll be randomly assigned to receive either this new medication or a traditional pain reliever when you need it after your operation.
This trial tests a new pain medicine (Tegileridine) against a standard one (Sufentanil) during laparoscopic surgery. It is for patients who have a high risk of nausea and vomiting after surgery.
This trial tests if a newer painkiller (oliceridine) causes less nausea after a specific type of brain surgery than the standard painkiller (sufentanil). If you are having CPA region surgery and will receive a patient-controlled pain pump, this study may help find a better option for managing pain with fewer side effects.
This trial tests if adding dexmedetomidine (a sedative) to bupivacaine (a numbing medicine) during a targeted nerve block reduces pain after upper abdominal cancer surgery. It may help patients wake up more comfortably and need fewer painkillers.
This trial tests whether using oxycodone and sufentanil helps control pain during one-sided hip surgery. It’s meant to see how well these pain medicines work and whether they are safe for patients in this setting.
Hear when a new Oral Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.